Decreasing sarcoplasmic reticular calcium gives rise to myocardial protection? —The effect of thapsigargin for myocardial protection under conditions of normothermia—
- 16 Downloads
Deceasing sarcoplasmic reticular (SR) calcium may contribute to the myocardiac protection against ischemia and reperfusion-induced injury. Therefore, using the isolated working rat heart model, we investigated the effect of Thapsigargin (TH)-induced SR calcium diminution on the myocardial protection when added either before onset of ischemia or at time of reperfusion under conditions of normothermic ischemia. Hearts (n=6/group) from male Wistar rats were aerobically (37°C) perfused (20 min) with bicarbonate buffer. In the experimental protocol A, this was followed by a 3 min infusion of St. Thomas’ Hospital cardioplegic solution No. 2 (STS) containing various concentrations of TH. Hearts were then subjected to 34 min of normothermic (37°C) global ischemia and 35 min of reperfusion (15 min Langendorff, 20 min working). Reperfusion cardiac functions at 20 min of working perfusion was measured and compared with the preischemia values. STS added to 0.1 and 0.25 μmol/L TH improved recovery of aortic flow after 20 min reperfusion from 47 ± 3% in the TH free controls to 62 ± 3, 63 ± 2% (n=6) (p<0.05). There was no difference in creatine kinase (CK) leakage during Langendorff reperfusion between the TH treated groups and the control group. In the experimental protocol B, 3 min of cardioplegia without TH and 34 min of ischemia (37°C) were followed by a 10 min Langendorff reperfusion with various concentrations of TH, then 10 min Langendroff reperfusion for washing out, and 20 min working reperfusion. When TH was added to reperfusate the recovery of aortic flow did not change. 0.5 μmol/L TH group had the detelious effect. Thus, TH, when added to the cardioplegia, enhanced myocardial protection. We conclude that lessened uptake of Ca2+ into sarcoplasmic reticulum by inhibitors of the Ca2+-ATPase pump can decrease ischemia and reperfusion-induced injury.
KeywordsCreatine Kinase Sarcoplasmic Reticular Ryanodine Thapsigargin Myocardial Protection
Unable to display preview. Download preview PDF.
- 6).Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ: Cardioplegia and slow channel blockers. Studies with verapamil. J Throac Cardiovasc Surg 86: 252–261, 1983Google Scholar
- 10).Yamamoto H, Yamamoto F, lchikawa H, Takahashi A, Fujita T: Effects of ryanodine on myocardial ischemia and reperfusion induced injury in isolated rat heart [Abstract]. J Mol Cell Cardiol 22: S-58, 1990Google Scholar
- 11).Akita T, Abe T, Kato S, Kodama I, Toyama J: Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit heart. J Throac Cardiovasc Surg 106: 55–66, 1993Google Scholar
- 14).Seider NW, Jona I, Vegh M, Martonosi A: Cyclopiazonic acid is a specific inhibitior of the Ca2+-ATPase of sarcoplasmic reticulum. J Biol Chem 264: 17816–17823, 1989Google Scholar
- 16).Hearse DJ, Braimbridge MV, Jynge P: Model and markers for the invastigation of myocardial tissure damage., In: Hearse DJ, Braimbridge MV, Jynge P, eds. Protection of the Ischemic Myocardium. Cardioplegia. New York, 1981, Raven Press p50–92Google Scholar
- 18).Iuni M, Wang S, Saito A, Fleischer S: Characterization of junctional and longitudinal sarcoplasmic reticulum from heart muscle. J Biol Chem 263: 10843–10850, 1988Google Scholar
- 24).Takemura H, Hughes AR, Thrastrup O, Putney JW Jr: Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intraellular calcium pool, and not an inositol phosphate, regulate calcium fluxes at the plasma membrane. J Biol Chem 264: 12266–12271, 1989PubMedGoogle Scholar